The FDA said it is investigating reports of e-cigarette users experiencing seizures. There have been a small number of cases over several years.
in retail stores. The agency said in its statement on Wednesday that in many of the seizure reports, it couldn't identify a specific brand or sub-brand of device.
Shares of tobacco makers who are trying to diversify away from traditional cigarettes by embracing electronic devices declined on Wednesday. Altria Group, which has a large stake in Juul Labs, fell nearly 5% to $53.98. Philip Morris International Inc. declined 2.5% to $85.81, while British American Tobacco shares slid nearly 3% to $40.27 in London trading.
An Altria spokesman declined to comment on the FDA alert. BAT didn't immediately respond to a request for comment. "It's clear this relates to usage reports on e-cigarettes currently available or used in the U.S.," said Philip Morris spokesman Corey Henry."Given that we don't sell or market any e-cigarettes, or any nicotine-containing products, in the U.S., it’s not really our place to address adverse effects/quality issues reported to FDA on products that aren't ours.", a device that would compete with Juul's and that is already sold in many countries.
In the reports the FDA received, some vapers reported a prior history of seizures and some reported they had used other substances such as marijuana or amphetamines along with e-cigarettes.The latest health and science updates, breakthroughs, research, and the best in investigative and informative journalism.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
FDA proposes mammogram changes for first time in 20 years to identify breast cancer earlyWomen with dense breasts will be notified that they are at a higher risk of developing breast cancer and that X-ray results aren't always as accurate for them.
और पढो »
Health officials want next FDA chief to crack down on teen vaping of e-cigarettes
और पढो »
FDA proposes new fluoride standard for bottled water, but some say it's still too highThe US Food and Drug Administration is proposing a lower concentration level standard for fluoride in bottled water, yet some scientists and environmental groups believe that the proposed limit is still too high and poses a danger to human health
और पढो »
FDA Commissioner Calls for Tighter Standard for Approval of New Opioid DrugsFDA Commissioner Scott Gottlieb is proposing that the agency take the novel step of approving new opioid painkillers only if they show comparative advantages over existing drugs.
और पढो »
FDA, FTC send warning letters to three CBD marketers for false medical claimsThe FDA and the FTC sent warning letters to 3 companies that market cannabidiol products, saying the companies are making false claims about treating diseases such as cancer and Alzheimer's.
और पढो »
FDA looks into regulating CBD in food, beverages and moreThe US Food and Drug Administration announced Tuesday that it will hold a public hearing next month to discuss developing a regulatory framework for the use of CBD in consumer products, including foods and beverages.
और पढो »
Outgoing FDA chief Scott Gottlieb gets personal about leaving 'the best job' he's ever hadAfter nearly two years at the helm of the FDA, Scott Gottlieb is resigning at the beginning of April.
और पढो »